Cargando…
Association between IL-1beta and cardiovascular disease risk in patients with newly diagnosed, drug-naïve type 2 diabetes mellitus: a cross-sectional study
BACKGROUND: To determine whether the pro-inflammatory cytokine interleukin (IL)-1beta, as a marker of the nucleotide binding and oligomerization domain-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation, can be used to predict cardiovascular disease (CVD) risk in patients...
Autores principales: | Joung, Kyong Hye, Kim, Ji Min, Choung, Sorim, Lee, Ju Hee, Kim, Hyun Jin, Ku, Bon Jeong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154468/ https://www.ncbi.nlm.nih.gov/pubmed/32309372 http://dx.doi.org/10.21037/atm.2020.01.17 |
Ejemplares similares
-
Serum Soluble Epidermal Growth Factor Receptor Level Increase in Patients Newly Diagnosed with Type 2 Diabetes Mellitus
por: Kim, Ji Min, et al.
Publicado: (2018) -
The Role of Circulating Slit2, the One of the Newly Batokines, in Human Diabetes Mellitus
por: Kang, Yea Eun, et al.
Publicado: (2017) -
Soluble LRIG2 is a potential biomarker for type 2 diabetes mellitus
por: Kim, Ji Min, et al.
Publicado: (2021) -
Clinical Implications of Using Post-Challenge Plasma Glucose Levels for Early Diagnosis of Type 2 Diabetes Mellitus in Older Individuals
por: Joung, Kyong Hye, et al.
Publicado: (2018) -
Association between Growth Differentiation Factor 15 (GDF15) and Cardiovascular Risk in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
por: Shin, Min Young, et al.
Publicado: (2016)